Both the i.t. and i.v. treatment with CF33-hNIS-anti-PD-L1 demonstrated some levels of anti-tumor efficacy and significantly increased survival of the virus-treated mice (Figures 10B and 10C). Here, CD274 is linked to neoplasm.